drugset / Trial / NCT01284764

Efficacy Study of a Low Volume of Water Intake and Mosapride for Endoscopy in Patients With Subtotal Gastrectomy

NCT01284764

Phase 3 Completed 144 enrolled Inje University
RandomizedParallel-groupDouble-blindDiagnostic

Summary

A low volume of water intake and mosapride will effectively reduce food residue in remnant stomach for patients who had undergone subtotal gastrectomy due to gastric cancer.

Timeline

Start
2011-01
Primary completion
2011-07
Completion
2011-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Mosapride Small molecule 10 mg

Indications

No indication recorded.